Tags

Type your tag names separated by a space and hit enter

Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.
J Appl Lab Med. 2020 09 01; 5(5):1107-1110.JA

Authors+Show Affiliations

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32609341

Citation

Wu, Alan H B.. "Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: a Counterargument." The Journal of Applied Laboratory Medicine, vol. 5, no. 5, 2020, pp. 1107-1110.
Wu AHB. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument. J Appl Lab Med. 2020;5(5):1107-1110.
Wu, A. H. B. (2020). Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument. The Journal of Applied Laboratory Medicine, 5(5), 1107-1110. https://doi.org/10.1093/jalm/jfaa104
Wu AHB. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: a Counterargument. J Appl Lab Med. 2020 09 1;5(5):1107-1110. PubMed PMID: 32609341.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument. A1 - Wu,Alan H B, PY - 2020/04/27/received PY - 2020/05/08/accepted PY - 2020/7/2/pubmed PY - 2020/9/24/medline PY - 2020/7/2/entrez SP - 1107 EP - 1110 JF - The journal of applied laboratory medicine JO - J Appl Lab Med VL - 5 IS - 5 SN - 2576-9456 UR - https://www.unboundmedicine.com/medline/citation/32609341/Screening_the_General_Population_for_SARS_CoV_2_Virus_and_COVID_19_Antibodies:_A_Counterargument_ DB - PRIME DP - Unbound Medicine ER -